je.st
news
Eli Lilly: The Blockbuster Combination Of Elanco And Novartis' Animal Health
2015-01-03 11:18:31| Biotech - Topix.net
Elanco has been recently authorized by the FTC to take over Novartis' Animal Health segment, along with a condition to sell off Novartis' Sentinel product line. This combination will raise Eli Lilly's global market rank to number 2 in the animal pharmaceutical market in terms of total revenue, following Zoetis, which has topped the list.
Tags: health
combination
animal
eli
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||